Vaccination program for children and under-18 population under clinical trials
Published By : Prameya News Bureau | December 07, 2021 IST
Share
New Delhi, Dec 7: National Expert Group on Vaccine Administration for Covid (NEGVAC) and National Technical Advisory Group on Immunization (NTAGI) are deliberating and considering scientific evidences related to vaccination of beneficiaries aged less than 18 years. Government of India has been supplying Covid-19 vaccines free of cost to the States/UTs for administration to prioritized beneficiaries as recommended by NEGVAC. ZyCoV-D vaccine manufactured by M/s Cadila Healthcare has received the approval for Restricted Use in Emergency Setting by the National Regulator i.e., Drug Controller General of India (DCGI) for the age group of 12 years and above based on the interim clinical data of Phase II &Phase III clinical trial conducted in the country. Following COVID-19 vaccines are under clinical trials in the country for age-group of less than 18 years: i. M/s Bharat Biotech is conducting Phase II/III clinical trial of COVAXIN on Healthy Volunteers aged 2 to 18 years & firm has submitted interim safety & immunogenicity data to the National Regulator. ii. M/s Serum institute of India is conducting Phase II/III clinical trial of Nanoparticle Vaccine (Liquid) (COVOVAX) in 920 subjects of >2 to 17 years age group. iii. M/s Biological E Ltd., is conducting Phase II/III clinical trial of RBD of SARS-CoV-2 gene in 624 subjects of ≥5 to <18years age group. iv. M/s Johnson & Johnson Pvt. Ltd., is conducting Phase II/III clinical trial of Ad.26COV.2S vaccine in age group of 12-17 years (Global Clinical trial wherein India is one of the clinical trial sites). The approval of aforementioned COVID-19 vaccines is dependent on the successful completion of clinical trials and submission of requisite data to the National Regulator i.e., Drug Controller General of India as per the requirements of New Drugs and Clinical Trials Rules, 2019 under Drugs and Cosmetics Act, 1940. The Union Minister of State for Health and Family Welfare, Dr Bharati Pravin Pawar stated this in a written reply in the Rajya Sabha today.
News7 Is Now On WhatsApp Join And Get Latest News Updates Delivered To You Via WhatsApp
You Might Also Like
More From Related News
Patient awareness and interaction programme marks World Liver Day at AIIMS Bhubaneswar
Rising cases of pediatric liver issues linked to junk food epidemic
Vital organ, vital importance: Why maintaining liver health matters
World Liver Day 2024: These factors contribute to liver damage
Nestle baby food sugar study causes concern in India, Nestle India's shares fall
World Voice Day observed at SUM Phulnakhara Campus
Cadaveric kidney transplant performed at SCB Hospital
Closure of regn counter sparks tension at Bhubaneswar AIIMS
From pain to comfort: Discover the doctor who cares for your bad back
Boys born to mothers with HIV more vulnerable to death in infancy
World Hemophilia Day: Solidarity for people living with rare genetic disorder
AIIMS Bhubaneswar launches advanced Artificial Urinary Sphincter(AUS) implantation service
Indians up their spending on dieticians by 125 pc in FY24: Report
Zomato introduces 'large order fleet' for gatherings of up to 50 people
Critical patient successfully treated at SUM Phulnakhara campus
Nasal cells shield kids from Covid, Study finds
Scientists decode how exercise can reverse ageing
Remove Bournvita from category of ‘health drinks’: Govt tells e-commerce firms
Menstruation signifies femininity and fertility, not impurity
44% Odisha people never check blood pressure: ICMY study